Cabot Corporation operates as a specialty chemicals and performance materials company. More Details
Reasonable growth potential average dividend payer.
Share Price & News
How has Cabot's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CBT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: CBT's weekly volatility (6%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: CBT underperformed the US Chemicals industry which returned 25.1% over the past year.
Return vs Market: CBT underperformed the US Market which returned 26% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Cabot's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StWe Wouldn't Be Too Quick To Buy Cabot Corporation (NYSE:CBT) Before It Goes Ex-Dividend
2 months ago | Simply Wall StWe're Watching These Trends At Cabot (NYSE:CBT)
2 months ago | Simply Wall StHere's Why Cabot (NYSE:CBT) Has A Meaningful Debt Burden
Is Cabot undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: CBT ($46.02) is trading above our estimate of fair value ($39.38)
Significantly Below Fair Value: CBT is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CBT is unprofitable, so we can't compare its PE Ratio to the US Chemicals industry average.
PE vs Market: CBT is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CBT's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CBT is overvalued based on its PB Ratio (3.8x) compared to the US Chemicals industry average (2.6x).
How is Cabot forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CBT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: CBT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CBT's is expected to become profitable in the next 3 years.
Revenue vs Market: CBT's revenue (0.2% per year) is forecast to grow slower than the US market (10.6% per year).
High Growth Revenue: CBT's revenue (0.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CBT's Return on Equity is forecast to be high in 3 years time (25.5%)
How has Cabot performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CBT is currently unprofitable.
Growing Profit Margin: CBT is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CBT is unprofitable, but has reduced losses over the past 5 years at a rate of 20.6% per year.
Accelerating Growth: Unable to compare CBT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CBT is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-16.3%).
Return on Equity
High ROE: CBT has a negative Return on Equity (-27.15%), as it is currently unprofitable.
How is Cabot's financial position?
Financial Position Analysis
Short Term Liabilities: CBT's short term assets ($978.0M) exceed its short term liabilities ($529.0M).
Long Term Liabilities: CBT's short term assets ($978.0M) do not cover its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: CBT's debt to equity ratio (133.2%) is considered high.
Reducing Debt: CBT's debt to equity ratio has increased from 76.3% to 133.2% over the past 5 years.
Debt Coverage: CBT's debt is well covered by operating cash flow (34.8%).
Interest Coverage: CBT is unprofitable, therefore interest payments are not well covered by earnings.
What is Cabot current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: CBT's dividend (3.04%) is higher than the bottom 25% of dividend payers in the US market (1.38%).
High Dividend: CBT's dividend (3.04%) is low compared to the top 25% of dividend payers in the US market (3.85%).
Stability and Growth of Payments
Stable Dividend: CBT's dividends per share have been stable in the past 10 years.
Growing Dividend: CBT's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: CBT is paying a dividend but the company is unprofitable.
Future Payout to Shareholders
Future Dividend Coverage: CBT's dividends in 3 years are forecast to be well covered by earnings (40.5% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Sean Keohane (53 yo)
Mr. Sean D. Keohane serves as Director of Chemours Company since May 3, 2018. He has been the Chief Executive Officer and President of Cabot Corporation since March 11, 2016. He was a member of the Interim...
CEO Compensation Analysis
Compensation vs Market: Sean's total compensation ($USD6.68M) is above average for companies of similar size in the US market ($USD5.01M).
Compensation vs Earnings: Sean's compensation has been consistent with company performance over the past year.
|Senior VP & CFO||2.67yrs||US$1.57m||0.054% |
|Senior VP & General Counsel||1.58yrs||US$1.32m||0.027% |
|Senior VP||4.75yrs||US$1.58m||0.089% |
|Senior VP & CTO||2.92yrs||no data||no data|
|VP of Investor Relations & Treasurer||4.5yrs||no data||no data|
|Corporate Communications Director||no data||no data||no data|
|Senior VP & Chief Human Resources Officer||3.75yrs||no data||no data|
|Senior VP of Safety||3.5yrs||no data||no data|
|Senior VP||8.75yrs||no data||0.11% |
|Senior VP & President of Formulated Solutions and President of The EMEA Region||2.25yrs||no data||no data|
|Senior VP & President of Purification Solutions Segment||no data||no data||no data|
Experienced Management: CBT's management team is considered experienced (3.6 years average tenure).
|Director||0.75yr||no data||0.0086% |
|Independent Director||24yrs||US$215.50k||0.084% |
|Independent Director||6.33yrs||US$219.96k||0.028% |
|Independent Director||15.83yrs||US$212.04k||0.0037% |
|Independent Director||3yrs||US$207.99k||0.017% |
|Independent Director||8.5yrs||US$217.21k||0.034% |
|Independent Non-Executive Chairman||2.83yrs||US$320.49k||0.038% |
|Independent Director||2.33yrs||US$210.25k||0.015% |
|Independent Director||1.67yrs||US$114.63k||0.012% |
|Independent Director||3.33yrs||US$229.28k||0.0035% |
|Director||no data||no data||no data|
Experienced Board: CBT's board of directors are considered experienced (3.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cabot Corporation's company bio, employee growth, exchange listings and data sources
- Name: Cabot Corporation
- Ticker: CBT
- Exchange: NYSE
- Founded: 1882
- Industry: Commodity Chemicals
- Sector: Materials
- Market Cap: US$2.666b
- Shares outstanding: 56.60m
- Website: https://www.cabotcorp.com
Number of Employees
- Cabot Corporation
- Two Seaport Lane
- Suite 1400
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CBT||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||Aug 1968|
|CBT||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Aug 1968|
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The co...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/25 23:04|
|End of Day Share Price||2021/01/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.